Glenmark Announces the Launch of Polyethylene Glycol 3350, Powder for Solution (OTC) in the US
Introduction
Glenmark Therapeutics Inc., USA, brought to market Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC), the generic equivalent of the active pharmaceutical ingredient in Bayer HealthCare LLC’s MiraLAX® Powder for Solution, 17 grams. The Glenmark launch increases its presence in the over-the-counter laxative market, which is in response to the increased demand for high-quality, affordable alternatives.
Market Overview: The Increased Demand for Over-the-Counter Laxatives
According to Nielsen syndicated data for the last 52 weeks through February 22, 2025, the market for MiraLAX® Powder for Solution, 17 grams (OTC) experienced approximately $555.7 million in annual sales. The market size reflects the strength of demand for effective laxative products, which creates the possibility for Glenmark to provide a reliable alternative.
Glenmark’s Dedication to Quality and Accessibility
Marc Kikuchi, Head of Business, North America, and President, made the statement in the release:
We are delighted to announce the availability of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful, in response to the growing demand for a new supplier in the segment. The new product is a testament to our commitment to meeting market demands and providing quality over-the-counter products for our customers.
Through the new product, Glenmark continues in its efforts to make healthcare essentials more accessible to consumers in the U.S.
Polyethylene Glycol 3350 is a type
Polyethylene Glycol 3350, or PEG 3350, is an osmotic laxative which is used very frequently to treat occasional constipation. PEG 3350 works by pulling water into the colon, softening stool, and prompting regular bowel movement. PEG 3350 is known to be effective, mild, and well-tolerated, which renders it the laxative of choice for individuals seeking non-stimulant laxative relief.
Key benefits of Glenmark’s Polyethylene Glycol 3350:
- Comparable to MiraLAX® – Same dose, same active ingredient
- Gentle yet effective – Provides effective relief from constipation with no harsh stimulants
- Available Over-the-Counter – Convenient and highly accessible to consumers
- High Quality at Reasonable Price – Economical choice by a renowned pharmaceutical company
Frequently Asked Questions (FAQs)
- What is Polyethylene Glycol 3350 used for?
Polyethylene Glycol 3350 is a laxative medication used to treat occasional constipation by softening the stool and stimulating bowel movements. - How does Polyethylene Glycol 3350 work? It functions as an osmotic laxative by pulling water into the colon, softening stools, and easing their passage.
- Is Glenmark Polyethylene Glycol 3350 the same as MiraLAX®? Yes, it shares the same active ingredient as MiraLAX® and is just as effective.
- Is it safe for long-term use? It is for short-term relief of constipation only. Use only under the direction of a healthcare provider for long-term use.
- How should I take Polyethylene Glycol 3350? Mix one capful (17 grams) with 4-8 ounces of water, fruit juice, or other liquid and take once a day or as directed by your healthcare professional.
- Are there any side effects?
There may be bloating, gas, cramping, or nausea in certain users. Consult a doctor if the symptoms persist. - Is the drug safe for use in children?
Polyethylene Glycol 3350 is for adults and persons aged 17 years and older. Consult with a pediatrician before its use in pediatric patients. - Is it habit-forming? No, Polyethylene Glycol 3350 is not a stimulant laxative and is not habit-forming
- Where can I buy Glenmark’s Polyethylene Glycol 3350?
You can buy it over-the-counter at major pharmacies, supermarkets, and online retail stores. - Is it safe to take with other medications? It is generally safe, but consult your doctor if you are taking other medications in order to avoid interactions.
Conclusion
Glenmark’s release of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC) is a strategic extension to meet the growing consumer demand for reliable laxative products. With the OTC laxative market growing, Glenmark’s new offering allows consumers to have an effective, affordable alternative to leading brands like MiraLAX®.
Disclaimer
Barawakar does not provide financial advice and the information on the website www.Barawakar.com is only for general use. Users of Barawakar accept full responsibility in the possibility of losing capital. Barawakar strives to provide correct information, but offers no guarantees regarding the accuracy or completeness of data given.
In case of any investments planning, make sure to seek professional counsel or do amplify your own research. The www.barawakar.com website is available to users without warranties on availability or functionality. By using this website, you accept the terms of these conditions.
For any questions, feel free to reach out to us.